Persistent Asset Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Centene
CNC
|
+$6.93M |
| 2 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$4.78M |
| 3 |
UnitedHealth
UNH
|
+$3.65M |
| 4 |
CVS Health
CVS
|
+$3.53M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$3.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$4.91M |
| 2 |
Encompass Health
EHC
|
+$3.58M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$3.43M |
| 4 |
Amgen
AMGN
|
+$3.35M |
| 5 |
Eli Lilly
LLY
|
+$2.53M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.9% |
| 2 | Financials | 13.82% |
| 3 | Miscellaneous | 11.7% |
| 4 | Technology | 6.61% |
| 5 | Consumer Discretionary | 5.8% |
Similar funds
Persistent Asset Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Persistent Asset Partners held 316 positions worth $145M, up 7.9% from $135M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Persistent Asset Partners deployed $7.44M of net new capital in Q3 2025, opening 137 new positions and adding to 28 existing holdings. Its largest new stake was Centene: 229,544 shares worth $8.19M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 52% a quarter earlier, followed by Financials and Miscellaneous.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $3.43M trimmed.
- Persistent Asset Partners's largest Q3 2025 buy was Centene: 229,544 shares worth $8.19M.
- Persistent Asset Partners added most to Regeneron Pharmaceuticals in Q3 2025, an estimated $3.17M increase.
- Persistent Asset Partners's biggest Q3 2025 reduction was iShares Bitcoin Trust, cutting an estimated $3.43M.
- Persistent Asset Partners fully exited Humana in Q3 2025, selling an estimated $4.91M.
- Persistent Asset Partners's ten largest holdings make up 27% of its $145M portfolio in Q3 2025.
- Persistent Asset Partners opened 137 new positions and closed 75 in Q3 2025.
- Persistent Asset Partners's portfolio value rose 7.9% quarter-over-quarter to $145M.
Based on Persistent Asset Partners's 13F filing for Q3 2025, filed 10 Nov 2025.